Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
11.51
0.00 (0.00%)
Nov 4, 2025, 4:00 PM EST
Extendicare Market Cap
Extendicare has a market cap or net worth of $977.46 million as of November 6, 2025. Its market cap has increased by 77.53% in one year.
Market Cap
977.46M
Enterprise Value
1.13B
Revenue
1.11B
Ranking
n/a
PE Ratio
16.03
Stock Price
$11.51
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has increased from 973.52M to 977.46M, an increase of 0.40%. That is a compound annual growth rate of 0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 977.46M | 58.51% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | 466.60M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |